CDK2 and cancer: Conversely, knockout of CDK2 can inhibit malignant proliferation and aerobic glycolysis of cancer cells by increasing SIRT5 expression, revealing a novel role for SIRT5 as a tumor suppressor regulated by upstream genes in cancer.